News

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...
The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...
A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.
Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...
Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...
Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.
AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...
Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...
Researchers have identified a potential strategy to protect against Alzheimer’s by increasing the clusterin (CLU) protein, ...
Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in ...